Created at Source Raw Value Validated value
June 4, 2021, 1 a.m. irct

[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: Standard treatment regimen according to the national protocol", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: Pentoxifylline group receiving 400 mg every 12 hours (Amin Pharmaceutical Company) plus colchicine half a mg every day (Mofid Pharma Pharmaceutical Company) orally in addition to the standard treatment regimen according to the national protocol (Ramsavier and corticosteroids) For 7-14 days depending on the patient's clinical condition", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1662, "treatment_name": "Colchicine+pentoxifylline", "treatment_type": "Metabolic agents+cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]